Cargando…
Inhibiting the proton pump: mechanisms, benefits, harms, and questions
Inhibition of the H(+)/K(+)-adenosine triphosphatase (the proton pump) is the final common mechanistic pathway in reducing gastric acid secretion pharmacologically. Proton pump inhibitors are widely used in upper gastrointestinal diseases, including gastric and duodenal ulcers, eradication of Helico...
Autor principal: | Aronson, Jeffrey K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101661/ https://www.ncbi.nlm.nih.gov/pubmed/27825384 http://dx.doi.org/10.1186/s12916-016-0724-1 |
Ejemplares similares
-
Harm-Benefit Analysis May Not Be the Best Approach to Ensure Minimal Harms and Maximal Benefits of Animal Research—Alternatives Should Be Explored
por: Gutfreund, Yoram
Publicado: (2020) -
When is proton pump inhibitor use appropriate?
por: Yadlapati, Rena, et al.
Publicado: (2017) -
Anti-infective properties of proton pump inhibitors: perspectives
por: da Rosa, Taciéli Fagundes, et al.
Publicado: (2021) -
Benefit, Necessity or Harm by Administering Heparin during Neurointerventional Procedures?
por: Berlis, Ansgar
Publicado: (2021) -
V-ATPase expression in gliomas—Not your grandparents' proton pump
por: Graner, Michael
Publicado: (2019)